The Role of Bone Morphogenetic Protein 7 (BMP-7) in Inflammation in Heart Diseases

Mazerbourg, 2006, Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands, Hum. Reprod. Update, 12, 373, 10.1093/humupd/dml014

Cho, 2001, Intracellular BMP signaling regulation in vertebrates: Pathway or network?, Dev. Biol., 239, 1, 10.1006/dbio.2001.0388

Bragdon, 2011, Bone morphogenetic proteins: A critical review, Cell. Signal., 23, 609, 10.1016/j.cellsig.2010.10.003

Miyazono, 2005, BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk, Cytokine Growth Factor Rev., 16, 251, 10.1016/j.cytogfr.2005.01.009

Xiao, 2007, Bone morphogenetic protein, Biochem. Biophys. Res. Commun., 362, 550, 10.1016/j.bbrc.2007.08.045

Chen, 1998, Differential Roles for Bone Morphogenetic Protein (BMP) Receptor Type IB and IA in Differentiation and Specification of Mesenchymal Precursor Cells to Osteoblast and Adipocyte Lineages, J. Cell Biol., 142, 295, 10.1083/jcb.142.1.295

Chen, 2012, TGF-beta and BMP signaling in osteoblast differentiation and bone formation, Int. J. Biol. Sci., 8, 272, 10.7150/ijbs.2929

Takada, I., Kouzmenko, A.P., and Kato, S. (2010). PPAR-gamma Signaling Crosstalk in Mesenchymal Stem Cells. PPAR Res., 2010.

Hata, 2003, Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis, Mol. Biol. Cell., 14, 545, 10.1091/mbc.e02-06-0356

Kang, 2009, A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells, Stem Cells Dev., 18, 545, 10.1089/scd.2008.0130

Dorman, 2012, In vitro effects of bmp-2, bmp-7, and bmp-13 on proliferation and differentation of mouse mesenchymal stem cells, Biomed. Sci. Instrum., 48, 81

Reid, 1982, Primary non-specific ulcer of the small intestine, J. R. Coll. Surg. Edinb., 27, 228

Varkey, 2006, In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments, Clin. Orthop. Relat. Res., 443, 113, 10.1097/01.blo.0000200236.84189.87

Granjeiro, 2005, Bone morphogenetic proteins: From structure to clinical use, Braz. J. Med. Biol. Res. Rev. Bras. Pesqui. Med. Biol., 38, 1463, 10.1590/S0100-879X2005001000003

Qian, 2013, BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis, Proc. Natl. Acad. Sci. USA, 110, E798, 10.1073/pnas.1215236110

Kalluri, 2006, Fibroblasts in cancer, Nat. Rev. Cancer, 6, 392, 10.1038/nrc1877

Friedrichs, M., Wirsdoerfer, F., Flohe, S.B., Schneider, S., Wuelling, M., and Vortkamp, A. (2011). BMP signaling balances proliferation and differentiation of muscle satellite cell descendants. BMC Cell Biol., 12.

Segklia, A., Seuntjens, E., Elkouris, M., Tsalavos, S., Stappers, E., Mitsiadis, T.A., Huylebroeck, D., Remboutsika, E., and Graf, D. (2012). Bmp7 regulates the survival, proliferation, and neurogenic properties of neural progenitor cells during corticogenesis in the mouse. PLoS ONE, 7.

Zhang, 1996, Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development, Development, 122, 2977, 10.1242/dev.122.10.2977

Winnier, 1995, Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse, Genes Dev., 9, 2105, 10.1101/gad.9.17.2105

Chen, 2004, BMP10 is essential for maintaining cardiac growth during murine cardiogenesis, Development, 131, 2219, 10.1242/dev.01094

Dudley, 1995, A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye, Genes Dev., 9, 2795, 10.1101/gad.9.22.2795

McPherron, 1999, Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11, Nat. Genet., 22, 260, 10.1038/10320

Komatsu, 2007, BMP type I receptor ALK2 is essential for proper patterning at late gastrulation during mouse embryogenesis, Dev. Dyn., 236, 512, 10.1002/dvdy.21021

Beppu, 2000, BMP type II receptor is required for gastrulation and early development of mouse embryos, Dev. Biol., 221, 249, 10.1006/dbio.2000.9670

Mishina, 1995, Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis, Genes Dev., 9, 3027, 10.1101/gad.9.24.3027

Sirard, 1998, The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo, Genes Dev., 12, 107, 10.1101/gad.12.1.107

Chang, 1999, Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects, Development, 126, 1631, 10.1242/dev.126.8.1631

Lechleider, 2001, Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion, Dev. Biol., 240, 157, 10.1006/dbio.2001.0469

Chen, 2009, Smad7 is required for the development and function of the heart, J. Biol. Chem., 284, 292, 10.1074/jbc.M807233200

Goldman, 2009, BMP4 regulates the hematopoietic stem cell niche, Blood, 114, 4393, 10.1182/blood-2009-02-206433

Ma, 2005, Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning, Development, 132, 5601, 10.1242/dev.02156

Tabin, 2006, Bmp2 instructs cardiac progenitors to form the heart-valve-inducing field, Dev. Biol., 295, 580, 10.1016/j.ydbio.2006.03.043

Dimitriou, 2005, Current concepts of molecular aspects of bone healing, Injury, 36, 1392, 10.1016/j.injury.2005.07.019

Carreira, 2014, Bone Morphogenetic Proteins: Structure, biological function and therapeutic applications, Arch. Biochem. Biophys., 561, 64, 10.1016/j.abb.2014.07.011

Kim, 2011, BMPs and their clinical potentials, BMB Rep., 44, 619, 10.5483/BMBRep.2011.44.10.619

Reddi, A.H. (2001). Bone morphogenetic proteins: From basic science to clinical applications. J. Bone Jt. Surg. Am. Vol., 83.

Geesink, 1999, Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect, J. Bone Jt. Surg. British Vol., 81, 710, 10.1302/0301-620X.81B4.0810710

Friedlaender, 2001, Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions, J. Bone Jt. Surg. Am. Vol., 83, 151, 10.2106/00004623-200100002-00010

Cummings, 2002, Epidemiology and outcomes of osteoporotic fractures, Lancet, 359, 1761, 10.1016/S0140-6736(02)08657-9

Giannoudis, 2007, Fracture healing in osteoporotic fractures: Is it really different? A basic science perspective, Injury, 38, 90, 10.1016/j.injury.2007.02.014

Qaseem, 2008, Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: A clinical practice guideline from the American College of Physicians, Ann. Intern. Med., 149, 404, 10.7326/0003-4819-149-6-200809160-00007

Chen, 2004, Bone morphogenetic proteins, Growth Factors, 22, 233, 10.1080/08977190412331279890

Nakase, 2006, Potential roles of bone morphogenetic proteins (BMPs) in skeletal repair and regeneration, J. Bone Miner. Metab., 24, 425, 10.1007/s00774-006-0718-8

Yamashita, 1994, Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4, J. Biol. Chem., 269, 16985, 10.1016/S0021-9258(17)32506-1

Hahn, 1992, A bone morphogenetic protein subfamily: Chromosomal localization of human genes for BMP5, BMP6, and BMP7, Genomics, 14, 759, 10.1016/S0888-7543(05)80181-8

Nonner, 2001, Bone morphogenetic proteins (BMP6 and BMP7) enhance the protective effect of neurotrophins on cultured septal cholinergic neurons during hypoglycemia, J. Neurochem., 77, 691, 10.1046/j.1471-4159.2001.00273.x

Solloway, 1998, Mice lacking Bmp6 function, Dev. Genet., 22, 321, 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.0.CO;2-8

Zhang, 2006, Inhibition of Bone Morphogenetic Protein 1 by Native and Altered Forms of α2-Macroglobulin, J. Biol. Chem., 281, 39096, 10.1074/jbc.M601362200

Luo, 1995, BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning, Genes Dev., 9, 2808, 10.1101/gad.9.22.2808

Halcsik, 2010, Expression, purification, bioactivity, and partial characterization of a recombinant human bone morphogenetic protein-7 produced in human 293T cells, Mol. Biotechnol., 46, 118, 10.1007/s12033-010-9287-0

Mills, 2008, Expression and characterization of a human BMP-7 variant with improved biochemical properties, Protein Expr. Purif., 57, 312, 10.1016/j.pep.2007.09.016

Isaacs, 1995, Cystine knots, Curr. Opin. Struct. Biol., 5, 391, 10.1016/0959-440X(95)80102-2

Sieber, 2009, Recent advances in BMP receptor signaling, Cytokine Growth Factor Rev., 20, 343, 10.1016/j.cytogfr.2009.10.007

Little, 2009, Bone morphogenetic protein heterodimers assemble heteromeric type I receptor complexes to pattern the dorsoventral axis, Nat. Cell. Biol., 11, 637, 10.1038/ncb1870

Aono, 1995, Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer, Biochem. Biophys. Res. Commun., 210, 670, 10.1006/bbrc.1995.1712

Hazama, 1995, Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system, Biochem. Biophys. Res. Commun., 209, 859, 10.1006/bbrc.1995.1578

Israel, 1996, Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo, Growth Factors, 13, 291, 10.3109/08977199609003229

Dimitriou, 2005, Application of recombinant BMP-7 on persistent upper and lower limb non-unions, Injury, 36, 51, 10.1016/j.injury.2005.10.010

Nishimatsu, 1998, Ventral mesoderm induction and patterning by bone morphogenetic protein heterodimers in Xenopus embryos, Mech. Dev., 74, 75, 10.1016/S0925-4773(98)00070-7

Schmid, 2000, Equivalent genetic roles for bmp7/snailhouse and bmp2b/swirl in dorsoventral pattern formation, Development, 127, 957, 10.1242/dev.127.5.957

Suzuki, 1997, Mesoderm induction by BMP-4 and -7 heterodimers, Biochem. Biophys. Res. Commun., 232, 153, 10.1006/bbrc.1997.6219

Kim, H.-S., Neugebauer, J., McKnite, A., Tilak, A., and Christian, J.L. (2019). BMP7 functions predominantly as a heterodimer with BMP2 or BMP4 during mammalian embryogenesis. BioRxiv, 686758.

Vaccaro, 2008, The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: Minimum 4-year follow-up of a pilot study, Spine J., 8, 457, 10.1016/j.spinee.2007.03.012

Boon, 2011, Bone morphogenetic protein 7: A broad-spectrum growth factor with multiple target therapeutic potency, Cytokine Growth Factor Rev., 22, 221, 10.1016/j.cytogfr.2011.08.001

Carreira, 2014, Bone morphogenetic proteins: Facts, challenges, and future perspectives, J. Dent. Res., 93, 335, 10.1177/0022034513518561

Rocher, 2012, Bone morphogenetic protein 7 polarizes THP-1 cells into M2 macrophages, Can. J. Physiol. Pharmacol., 90, 947, 10.1139/y2012-102

Cecchi, 2015, Bone morphogenetic protein-7: Review of signalling and efficacy in fracture healing, J. Orthop. Translat., 4, 28, 10.1016/j.jot.2015.08.001

Singla, D.K., Singla, R., and Wang, J. (2016). BMP-7 Treatment Increases M2 Macrophage Differentiation and Reduces Inflammation and Plaque Formation in Apo E-/- Mice. PLoS ONE, 11.

Rocher, C., and Singla, D.K. (2013). SMAD-PI3K-Akt-mTOR pathway mediates BMP-7 polarization of monocytes into M2 macrophages. PLoS ONE, 8.

Shoulders, 2019, Macrophage depletion by clodronate attenuates bone morphogenetic protein-7 induced M2 macrophage differentiation and improved systolic blood velocity in atherosclerosis, Transl. Res., 203, 1, 10.1016/j.trsl.2018.07.006

Chattopadhyay, 2017, Bone morphogenetic protein-7 (BMP-7) augments insulin sensitivity in mice with type II diabetes mellitus by potentiating PI3K/AKT pathway, Biofactors, 43, 195, 10.1002/biof.1334

Rosenzweig, 1995, Cloning and characterization of a human type II receptor for bone morphogenetic proteins, Proc. Natl. Acad. Sci. USA, 92, 7632, 10.1073/pnas.92.17.7632

Miyazono, 2010, Bone morphogenetic protein receptors and signal transduction, J. Biochem., 147, 35, 10.1093/jb/mvp148

Ulsamer, 2008, BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38, J. Biol. Chem., 283, 3816, 10.1074/jbc.M704724200

Franceschi, 2003, Regulation of the osteoblast-specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways, J. Cell. Biochem., 88, 446, 10.1002/jcb.10369

Lee, 2002, Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein, Oncogene, 21, 7156, 10.1038/sj.onc.1205937

Morrell, 2016, Targeting BMP signalling in cardiovascular disease and anaemia, Nat. Rev. Cardiol., 13, 106, 10.1038/nrcardio.2015.156

Feng, 2005, Specificity and versatility in tgf-beta signaling through Smads, Annu. Rev. Cell. Dev. Biol., 21, 659, 10.1146/annurev.cellbio.21.022404.142018

Wu, 2016, TGF-beta and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease, Bone Res., 4, 16009, 10.1038/boneres.2016.9

Hoodless, 1998, Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2, J. Biol. Chem., 273, 25628, 10.1074/jbc.273.40.25628

Pal, 2006, Role of smad- and wnt-dependent pathways in embryonic cardiac development, Stem Cells Dev., 15, 29, 10.1089/scd.2006.15.29

Ebisawa, 1999, Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation, J. Cell Sci., 112, 3519, 10.1242/jcs.112.20.3519

Lavery, 2009, New insights into BMP-7 mediated osteoblastic differentiation of primary human mesenchymal stem cells, Bone, 45, 27, 10.1016/j.bone.2009.03.656

Yeh, 2002, Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12, J. Cell Biochem., 87, 292, 10.1002/jcb.10315

Zhang, 2005, BMP signaling and stem cell regulation, Dev. Biol., 284, 1, 10.1016/j.ydbio.2005.05.009

Herpin, 2007, Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes, FEBS J., 274, 2977, 10.1111/j.1742-4658.2007.05840.x

Yamaguchi, 1999, XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway, EMBO J., 18, 179, 10.1093/emboj/18.1.179

Chen, 2014, BMP-7 enhances cell migration and αvβ3 integrin expression via a c-Src-dependent pathway in human chondrosarcoma cells, PLoS ONE, 9, e112636, 10.1371/journal.pone.0112636

Yeh, 2009, The antioxidative effect of bone morphogenetic protein-7 against high glucose-induced oxidative stress in mesangial cells, Biochem. Biophys. Res. Commun., 382, 292, 10.1016/j.bbrc.2009.03.011

Yeh, 2010, Protein kinase D mediates the synergistic effects of BMP-7 and IGF-I on osteoblastic cell differentiation, Growth Factors, 28, 318, 10.3109/08977191003766874

Giese, 2016, An investigation of BMP-7 mediated alterations to BMP signalling components in human tenocyte-like cells, Sci. Rep., 6, 29703, 10.1038/srep29703

Hu, 2004, p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1, J. Biol. Chem., 279, 12051, 10.1074/jbc.M310526200

Blank, 2009, BMP7 promotes proliferation of nephron progenitor cells via a JNK-dependent mechanism, Development, 136, 3557, 10.1242/dev.036335

Sovershaev, 2015, BMP-7 induces TF expression in human monocytes by increasing F3 transcriptional activity, Thromb. Res., 135, 398, 10.1016/j.thromres.2014.11.031

Shimizu, 2012, Bone morphogenetic protein (BMP)-4 and BMP-7 suppress granulosa cell apoptosis via different pathways: BMP-4 via PI3K/PDK-1/Akt and BMP-7 via PI3K/PDK-1/PKC, Biochem. Biophys. Res. Commun., 417, 869, 10.1016/j.bbrc.2011.12.064

Weichhart, 2008, The PI3K/Akt/mTOR pathway in innate immune cells: Emerging therapeutic applications, Ann. Rheum. Dis., 67, 70, 10.1136/ard.2008.098459

Rauh, 2005, SHIP represses the generation of alternatively activated macrophages, Immunity, 23, 361, 10.1016/j.immuni.2005.09.003

Gazzerro, 1998, Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts, J. Clin. Investig., 102, 2106, 10.1172/JCI3459

Dionne, 2001, Mutation and analysis of Dan, the founding member of the Dan family of transforming growth factor beta antagonists, Mol. Cell. Biol., 21, 636, 10.1128/MCB.21.2.636-643.2001

Ideno, 2009, Protein related to DAN and cerberus (PRDC) inhibits osteoblastic differentiation and its suppression promotes osteogenesis in vitro, Exp. Cell. Res., 315, 474, 10.1016/j.yexcr.2008.11.019

Topol, 2000, Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin, J. Biol. Chem., 275, 8785, 10.1074/jbc.275.12.8785

Sudo, 2004, Protein related to DAN and cerberus is a bone morphogenetic protein antagonist that participates in ovarian paracrine regulation, J. Biol. Chem., 279, 23134, 10.1074/jbc.M402376200

Balemans, 2002, Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators, Dev. Biol., 250, 231, 10.1006/dbio.2002.0779

Rahman, 2015, TGF-beta/BMP signaling and other molecular events: Regulation of osteoblastogenesis and bone formation, Bone Res., 3, 15005, 10.1038/boneres.2015.5

Itoh, 2007, Negative regulation of TGF-beta receptor/Smad signal transduction, Curr. Opin. Cell Biol., 19, 176, 10.1016/j.ceb.2007.02.015

Knockaert, 2006, Unique players in the BMP pathway: Small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling, Proc. Natl. Acad. Sci. USA, 103, 11940, 10.1073/pnas.0605133103

Heldin, 2012, Role of Smads in TGFbeta signaling, Cell Tissue Res., 347, 21, 10.1007/s00441-011-1190-x

Larman, 2009, Chordin-like 1 and twisted gastrulation 1 regulate BMP signaling following kidney injury, J. Am. Soc. Nephrol., 20, 1020, 10.1681/ASN.2008070768

Matzuk, 1995, Multiple defects and perinatal death in mice deficient in follistatin, Nature, 374, 360, 10.1038/374360a0

Amthor, 2002, Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth, Dev. Biol., 243, 115, 10.1006/dbio.2001.0555

Li, 2018, Gremlin2 Regulates the Differentiation and Function of Cardiac Progenitor Cells via the Notch Signaling Pathway, Cell. Physiol. Biochem., 47, 579, 10.1159/000490012

Sasai, 1995, Regulation of neural induction by the Chd and Bmp-4 antagonistic patterning signals in Xenopus, Nature, 377, 757, 10.1038/377757a0

Bachiller, 2000, The organizer factors Chordin and Noggin are required for mouse forebrain development, Nature, 403, 658, 10.1038/35001072

Wijgerde, 2005, Noggin antagonism of BMP4 signaling controls development of the axial skeleton in the mouse, Dev. Biol., 286, 149, 10.1016/j.ydbio.2005.07.016

Coffinier, 2001, Neuralin-1 is a novel Chordin-related molecule expressed in the mouse neural plate, Mech. Dev., 100, 119, 10.1016/S0925-4773(00)00507-4

Nakayama, 2001, A novel chordin-like protein inhibitor for bone morphogenetic proteins expressed preferentially in mesenchymal cell lineages, Dev. Biol., 232, 372, 10.1006/dbio.2001.0200

Sakuta, 2001, Ventroptin: A BMP-4 antagonist expressed in a double-gradient pattern in the retina, Science, 293, 111, 10.1126/science.1058379

Ikeya, 2006, Essential pro-Bmp roles of crossveinless 2 in mouse organogenesis, Development, 133, 4463, 10.1242/dev.02647

Rentzsch, 2006, Crossveinless 2 is an essential positive feedback regulator of Bmp signaling during zebrafish gastrulation, Development, 133, 801, 10.1242/dev.02250

Zakin, 2008, Development of the vertebral morphogenetic field in the mouse: Interactions between Crossveinless-2 and Twisted Gastrulation, Dev. Biol., 323, 6, 10.1016/j.ydbio.2008.08.019

Yao, 2012, Crossveinless 2 regulates bone morphogenetic protein 9 in human and mouse vascular endothelium, Blood, 119, 5037, 10.1182/blood-2011-10-385906

Reichert, 2013, A BMP regulatory network controls ectodermal cell fate decisions at the neural plate border, Development, 140, 4435, 10.1242/dev.098707

Dyer, 2014, BMPER-induced BMP signaling promotes coronary artery remodeling, Dev. Biol., 386, 385, 10.1016/j.ydbio.2013.12.019

Lin, 2005, Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease, Nat. Med., 11, 387, 10.1038/nm1217

Soofi, 2013, Kielin/chordin-like protein attenuates both acute and chronic renal injury, J. Am. Soc. Nephrol., 24, 897, 10.1681/ASN.2012070759

Ivkovic, 2003, Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development, Development, 130, 2779, 10.1242/dev.00505

Maeda, 2009, CCN family 2/connective tissue growth factor modulates BMP signalling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes, J. Biochem., 145, 207, 10.1093/jb/mvn159

Mundy, 2014, Connective tissue growth factor (CTGF/CCN2) negatively regulates BMP-2 induced osteoblast differentiation and signaling, J. Cell. Physiol., 229, 672, 10.1002/jcp.24491

Glass, 2001, Atherosclerosis. the road ahead, Cell, 104, 503, 10.1016/S0092-8674(01)00238-0

Libby, 2002, Inflammation in atherosclerosis, Nature, 420, 868, 10.1038/nature01323

Hansson, 2005, Inflammation, atherosclerosis, and coronary artery disease, N. Engl. J. Med., 352, 1685, 10.1056/NEJMra043430

Bentzon, 2014, Mechanisms of plaque formation and rupture, Circ. Res., 114, 1852, 10.1161/CIRCRESAHA.114.302721

Parthasarathy, S. (1994). Modified Lipoproteins in the Pathogenesis of Atherosclerosis, RG Landes Co.

Steinberg, 2005, Thematic review series: The pathogenesis of atherosclerosis: An interpretive history of the cholesterol controversy, part III: Mechanistically defining the role of hyperlipidemia, J. Lipid. Res., 46, 2037, 10.1194/jlr.R500010-JLR200

Galkina, 2007, Leukocyte influx in atherosclerosis, Curr. Drug Targets, 8, 1239, 10.2174/138945007783220650

Weber, 2008, The multifaceted contributions of leukocyte subsets to atherosclerosis: Lessons from mouse models, Nat. Rev. Immunol., 8, 802, 10.1038/nri2415

Libby, 2013, Immune effector mechanisms implicated in atherosclerosis: From mice to humans, Immunity, 38, 1092, 10.1016/j.immuni.2013.06.009

Steven, 2019, Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease, Oxidative Med. Cell. Longev., 2019, 26, 10.1155/2019/7092151

Steinberg, 1990, Lipoproteins and atherogenesis. Current concepts, Jama, 264, 3047, 10.1001/jama.1990.03450230083034

Ross, 1993, The pathogenesis of atherosclerosis: A perspective for the 1990s, Nature, 362, 801, 10.1038/362801a0

Swirski, 2006, Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease, Proc. Natl. Acad. Sci. USA, 103, 10340, 10.1073/pnas.0604260103

Hahn, 2009, Mechanotransduction in vascular physiology and atherogenesis, Na. Rev. Mol. Cell Biol., 10, 53, 10.1038/nrm2596

Bi, 2019, M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment, Neural Plast., 2019, 21, 10.1155/2019/6724903

Stienstra, 2011, Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: A crucial role for Kruppel-like factor 2, Atherosclerosis, 214, 345, 10.1016/j.atherosclerosis.2010.11.018

Martinon, 2010, Signaling by ROS drives inflammasome activation, Eur. J. Immunol., 40, 616, 10.1002/eji.200940168

Baron, 2011, Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARgamma and LXRalpha pathways, Circ. Res., 108, 985, 10.1161/CIRCRESAHA.110.233775

Abdelbaky, 2013, Focal arterial inflammation precedes subsequent calcification in the same location: A longitudinal FDG-PET/CT study, Circ. Cardiovasc. Imaging, 6, 747, 10.1161/CIRCIMAGING.113.000382

Bobryshev, 2005, Transdifferentiation of smooth muscle cells into chondrocytes in atherosclerotic arteries in situ: Implications for diffuse intimal calcification, J. Pathol., 205, 641, 10.1002/path.1743

Lanzer, 2014, Medial vascular calcification revisited: Review and perspectives, Eur. Heart. J., 35, 1515, 10.1093/eurheartj/ehu163

Hruska, 2005, Bone morphogenetic proteins in vascular calcification, Circ. Res., 97, 105, 10.1161/01.RES.00000175571.53833.6c

Riad, 2018, A Novel Mechanism for Atherosclerotic Calcification: Potential Resolution of the Oxidation Paradox, Antioxid. Redox Signal., 29, 471, 10.1089/ars.2017.7362

Nakaoka, 1997, Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2, J. Clin. Investig., 100, 2824, 10.1172/JCI119830

Wong, 2003, BMP-2 inhibits proliferation of human aortic smooth muscle cells via p21Cip1/Waf1, Am. J. Physiol. Endocrinol. Metab., 284, E972, 10.1152/ajpendo.00385.2002

Matsushita, 1998, Inhibition of growth of human vascular smooth muscle cells by overexpression of p21 gene through induction of apoptosis, Hypertension, 31, 493, 10.1161/01.HYP.31.1.493

Dorai, 2000, Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro, J. Cell. Physiol., 184, 37, 10.1002/(SICI)1097-4652(200007)184:1<37::AID-JCP4>3.0.CO;2-M

Dorai, 2001, Bone morphogenetic protein-7 modulates genes that maintain the vascular smooth muscle cell phenotype in culture, J. Bone Jt. Surg. Am. Vol., 83, 70, 10.2106/00004623-200100001-00010

Li, 2008, BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells, Atherosclerosis, 199, 271, 10.1016/j.atherosclerosis.2007.11.031

Tobin, 2006, Bone morphogenetic proteins and growth differentiation factors as drug targets in cardiovascular and metabolic disease, Drug. Discov. Today, 11, 405, 10.1016/j.drudis.2006.03.016

Vattikuti, 2004, Osteogenic regulation of vascular calcification: An early perspective, Am. J. Physiol. Endocrinol. Metab., 286, E686, 10.1152/ajpendo.00552.2003

Johnson, 2006, Vascular calcification: Pathobiological mechanisms and clinical implications, Circ. Res., 99, 1044, 10.1161/01.RES.0000249379.55535.21

Davies, 2003, BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure, J. Am. Soc. Nephrol., 14, 1559, 10.1097/01.ASN.0000068404.57780.DD

Morrell, 2001, Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins, Circulation, 104, 790, 10.1161/hc3201.094152

Kang, 2010, Bone morphogenetic protein-7 inhibits vascular calcification induced by high vitamin D in mice, Tohoku J. Exp. Med., 221, 299, 10.1620/tjem.221.299

Lu, 2015, Myocardial Infarction: Symptoms and Treatments, Cell Biochem. Biophys., 72, 865, 10.1007/s12013-015-0553-4

Swynghedauw, 1999, Molecular mechanisms of myocardial remodeling, Physiol. Rev., 79, 215, 10.1152/physrev.1999.79.1.215

Holmes, 2005, Structure and mechanics of healing myocardial infarcts, Annu. Rev. Biomed. Eng., 7, 223, 10.1146/annurev.bioeng.7.060804.100453

Jugdutt, 2003, Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways, Curr. Drug Targets Cardiovasc. Haematol. Disord., 3, 1, 10.2174/1568006033337276

Jugdutt, 2003, Ventricular remodeling after infarction and the extracellular collagen matrix: When is enough enough?, Circulation, 108, 1395, 10.1161/01.CIR.0000085658.98621.49

Jugdutt, 2002, Vascular remodeling during healing after myocardial infarction in the dog model: Effects of reperfusion, amlodipine and enalapril, J. Am. Coll. Cardiol., 39, 1538, 10.1016/S0735-1097(02)01805-3

Alibhai, 2014, Short-term disruption of diurnal rhythms after murine myocardial infarction adversely affects long-term myocardial structure and function, Circ. Res., 114, 1713, 10.1161/CIRCRESAHA.114.302995

Nahrendorf, 2007, The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions, J. Exp. Med., 204, 3037, 10.1084/jem.20070885

Dewald, 2005, CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts, Circ. Res., 96, 881, 10.1161/01.RES.0000163017.13772.3a

Zouggari, 2013, B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction, Nat. Med., 19, 1273, 10.1038/nm.3284

Hilgendorf, 2014, Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium, Circ. Res., 114, 1611, 10.1161/CIRCRESAHA.114.303204

Frangogiannis, 2002, The inflammatory response in myocardial infarction, Cardiovasc. Res., 53, 31, 10.1016/S0008-6363(01)00434-5

Fadok, 1998, Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF, J. Clin. Investig., 101, 890, 10.1172/JCI1112

Xiao, 2006, Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages, J. Biol. Chem., 281, 38376, 10.1074/jbc.M605146200

Korns, 2011, Modulation of macrophage efferocytosis in inflammation, Front. Immunol., 2, 57, 10.3389/fimmu.2011.00057

Narula, 1996, Apoptosis in myocytes in end-stage heart failure, N. Engl. J. Med., 335, 1182, 10.1056/NEJM199610173351603

Sharov, 1996, Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure, Am. J. Pathol., 148, 141

Intengan, 2001, Vascular remodeling in hypertension: Roles of apoptosis, inflammation, and fibrosis, Hypertension, 38, 581, 10.1161/hy09t1.096249

Buja, 2008, Cardiomyocyte death and renewal in the normal and diseased heart, Cardiovasc. Pathol., 17, 349, 10.1016/j.carpath.2008.02.004

Talman, 2016, Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration, Cell Tissue Res., 365, 563, 10.1007/s00441-016-2431-9

Barin, 2012, Macrophage diversity in cardiac inflammation: A review, Immunobiology, 217, 468, 10.1016/j.imbio.2011.06.009

Ma, F., Li, Y., Jia, L., Han, Y., Cheng, J., Li, H., Qi, Y., and Du, J. (2012). Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF beta/Smad activation and cardiac fibrosis induced by angiotensin II. PLoS ONE, 7.

Martinez, 2014, The M1 and M2 paradigm of macrophage activation: Time for reassessment, F1000Prime Rep., 6, 13, 10.12703/P6-13

Aoyagi, 2011, The Cardiomyocyte as a Source of Cytokines in Cardiac Injury, J. Cell Sci. Ther., 2012, 003

Han, 2012, The pro-inflammatory role of TGFβ1: A paradox?, Int. J. Biol. Sci., 8, 228, 10.7150/ijbs.8.228

Sanjabi, 2009, Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity, Curr. Opin. Pharmacol., 9, 447, 10.1016/j.coph.2009.04.008

Ramesh, 2009, Transforming growth factor beta (TGFbeta)-induced apoptosis: The rise & fall of Bim, Cell Cycle, 8, 11, 10.4161/cc.8.1.7291

Cucoranu, 2005, NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts, Circ. Res., 97, 900, 10.1161/01.RES.0000187457.24338.3D

Hao, 1999, Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing, J. Mol. Cell. Cardiol., 31, 667, 10.1006/jmcc.1998.0902

Li, 2005, Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells, Circulation, 111, 2438, 10.1161/01.CIR.0000167553.49133.81

Yang, 2015, Exogenous cytochrome c inhibits the expression of transforming growth factor-beta1 in a mouse model of sepsis-induced myocardial dysfunction via the SMAD1/5/8 signaling pathway, Mol. Med. Rep., 12, 2189, 10.3892/mmr.2015.3629

Hao, 2000, Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro, Am. J. Physiol. Heart Circ. Physiol., 279, 3020, 10.1152/ajpheart.2000.279.6.H3020

Schneiders, 2005, SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytes, Cardiovasc. Res., 67, 87, 10.1016/j.cardiores.2005.02.021

Heger, 2011, TGFbeta receptor activation enhances cardiac apoptosis via SMAD activation and concomitant NO release, J. Cell. Physiol., 226, 2683, 10.1002/jcp.22619

Gabriel, 2009, Transforming growth factor-beta and angiotensin in fibrosis and burn injuries, J. Burn Care Res., 30, 471, 10.1097/BCR.0b013e3181a28ddb

Rosenkranz, 2002, Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1), Am. J. Physiol. Heart Circ. Physiol., 283, H1253, 10.1152/ajpheart.00578.2001

Ghosh, 2012, PAI-1 in tissue fibrosis, J. Cell. Physiol., 227, 493, 10.1002/jcp.22783

Derynck, 2003, Smad-dependent and Smad-independent pathways in TGF-beta family signalling, Nature, 425, 577, 10.1038/nature02006

Engel, 1999, Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription, J. Biol. Chem., 274, 37413, 10.1074/jbc.274.52.37413

Yu, 2002, TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses, EMBO J., 21, 3749, 10.1093/emboj/cdf366

Hayashi, 1997, The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling, Cell, 89, 1165, 10.1016/S0092-8674(00)80303-7

Walton, 2017, Targeting TGF-beta Mediated SMAD Signaling for the Prevention of Fibrosis, Front. Pharmacol., 8, 461, 10.3389/fphar.2017.00461

Zeisberg, 2003, Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models, Am. J. Physiol. Renal. Physiol., 285, 1060, 10.1152/ajprenal.00191.2002

Kinoshita, 2007, Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats, Gut, 56, 706, 10.1136/gut.2006.092460

Liang, 2016, BMP-7 attenuated silica-induced pulmonary fibrosis through modulation of the balance between TGF-beta/Smad and BMP-7/Smad signaling pathway, Chem. Biol. Interact., 243, 72, 10.1016/j.cbi.2015.11.012

Vukicevic, 1998, Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat, J. Clin. Investig., 102, 202, 10.1172/JCI2237

Jin, 2018, Exogenous BMP-7 Facilitates the Recovery of Cardiac Function after Acute Myocardial Infarction through Counteracting TGF-beta1 Signaling Pathway, Tohoku J. Exp. Med., 244, 1, 10.1620/tjem.244.1

Zhao, M., Zheng, S., Yang, J., Wu, Y., Ren, Y., Kong, X., Li, W., and Xuan, J. (2015). Suppression of TGF-beta1/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats. PLoS ONE, 10.

Merino, 2016, BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery, Cardiovasc. Res., 110, 331, 10.1093/cvr/cvw076

Zimmet, 2017, Diabetes and its drivers: The largest epidemic in human history?, Clin. Diabetes Endocrinol., 3, 1, 10.1186/s40842-016-0039-3

Maahs, 2010, Epidemiology of type 1 diabetes, Endocrinol. Metab. Clin. North Am., 39, 481, 10.1016/j.ecl.2010.05.011

Nathan, 2007, Impaired Fasting Glucose and Impaired Glucose Tolerance, Implic. Care, 30, 753

Aragno, 2004, Oxidative stress impairs skeletal muscle repair in diabetic rats, Diabetes, 53, 1082, 10.2337/diabetes.53.4.1082

Bloomgarden, 2005, Diabetic nephropathy, Diabetes Care, 28, 745, 10.2337/diacare.28.3.745

Bloomgarden, 2007, Diabetic retinopathy and diabetic neuropathy, Diabetes Care, 30, 760, 10.2337/dc07-zb03

Howarth, 2011, Left ventricle structural remodelling in the prediabetic Goto-Kakizaki rat, Exp. Physiol., 96, 875, 10.1113/expphysiol.2011.058271

Oberley, 1988, Free radicals and diabetes, Free Radic. Biol. Med., 5, 113, 10.1016/0891-5849(88)90036-6

Wolff, 1991, Protein glycation and oxidative stress in diabetes mellitus and ageing, Free Radic. Biol. Med., 10, 339, 10.1016/0891-5849(91)90040-A

Baynes, 1999, Role of oxidative stress in diabetic complications: A new perspective on an old paradigm, Diabetes, 48, 1, 10.2337/diabetes.48.1.1

Baynes, 1991, Role of oxidative stress in development of complications in diabetes, Diabetes, 40, 405, 10.2337/diab.40.4.405

Pickup, 1998, Is type II diabetes mellitus a disease of the innate immune system?, Diabetologia, 41, 1241, 10.1007/s001250051058

Muller, 2002, Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors, Diabetologia, 45, 805, 10.1007/s00125-002-0829-2

Pickup, 2000, Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes, Life Sci., 67, 291, 10.1016/S0024-3205(00)00622-6

Rehman, 2017, Role of Interleukin-6 in Development of Insulin Resistance and Type 2 Diabetes Mellitus, Crit. Rev. Eukaryot. Gene Expr., 27, 229, 10.1615/CritRevEukaryotGeneExpr.2017019712

Dhingra, 2011, Akt regulates IL-10 mediated suppression of TNFα-induced cardiomyocyte apoptosis by upregulating Stat3 phosphorylation, PLoS ONE, 6, e25009, 10.1371/journal.pone.0025009

Chowdhry, 2007, Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: Role of caspases and poly-adenosine diphosphate-ribose polymerase, J. Thorac Cardiovasc. Surg., 134, 124, 10.1016/j.jtcvs.2006.12.059

Li, 2007, Involvement of endoplasmic reticulum stress in myocardial apoptosis of streptozocin-induced diabetic rats, J. Clin. Biochem. Nutr., 41, 58, 10.3164/jcbn.2007008

Picatoste, 2009, Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes, Am. J. Physiol. Heart Circ. Physiol., 297, H2109, 10.1152/ajpheart.00157.2009

Izumi, 2001, Bone morphogenetic protein-2 inhibits serum deprivation-induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway, J. Biol. Chem., 276, 31133, 10.1074/jbc.M101463200

Urbina, 2014, BMP-7 attenuates adverse cardiac remodeling mediated through M2 macrophages in prediabetic cardiomyopathy, Am. J. Physiol. Heart Circ. Physiol., 307, H762, 10.1152/ajpheart.00367.2014

Stiles, 2005, Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue, Mol. Cell. Biol., 25, 2498, 10.1128/MCB.25.6.2498-2510.2005

Moroni, 2019, The Role of Monocytes and Macrophages in Human Atherosclerosis, Plaque Neoangiogenesis, and Atherothrombosis, Mediators Inflamm., 2019, 11, 10.1155/2019/7434376

Giannarelli, 2018, Manipulating Macrophage Polarization to Fix the Broken Heart: Challenges and Hopes, J. Am. Coll. Cardiol., 72, 905, 10.1016/j.jacc.2018.06.019

Nikiforov, 2019, Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach, Front. Pharmacol., 10, 725, 10.3389/fphar.2019.00725

Woollard, 2010, Monocytes in atherosclerosis: Subsets and functions, Nat. Rev. Cardiol., 7, 77, 10.1038/nrcardio.2009.228

Lampiasi, 2016, The Alternative Faces of Macrophage Generate Osteoclasts, BioMed Res. Int., 2016, 9, 10.1155/2016/9089610

Zizzo, 2013, IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids, J. Immunol., 190, 5237, 10.4049/jimmunol.1203017

Sinha, 2005, Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis, Cancer Res., 65, 11743, 10.1158/0008-5472.CAN-05-0045

Weis, 2009, Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants, Mol. Biol. Cell., 20, 1280, 10.1091/mbc.e08-10-1005

Xu, 2006, IL-10-producing macrophages preferentially clear early apoptotic cells, Blood, 107, 4930, 10.1182/blood-2005-10-4144

Libby, 2009, Inflammation in atherosclerosis: From pathophysiology to practice, J. Am. Coll. Cardiol., 54, 2129, 10.1016/j.jacc.2009.09.009

Galkina, 2009, Immune and inflammatory mechanisms of atherosclerosis (*), Annu. Rev. Immunol., 27, 165, 10.1146/annurev.immunol.021908.132620

Moore, 2011, Macrophages in the pathogenesis of atherosclerosis, Cell, 145, 341, 10.1016/j.cell.2011.04.005

Seimon, 2009, Mechanisms and consequences of macrophage apoptosis in atherosclerosis, J. Lipid. Res., 50, 382, 10.1194/jlr.R800032-JLR200

Tardif, 2009, The BMP antagonists follistatin and gremlin in normal and early osteoarthritic cartilage: An immunohistochemical study, Osteoarthr. Cartil., 17, 263, 10.1016/j.joca.2008.06.022

Araki, 2011, TOR in the immune system, Curr. Opin. Cell. Biol., 23, 707, 10.1016/j.ceb.2011.08.006

Martin, 2003, Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide, J. Immunol., 171, 717, 10.4049/jimmunol.171.2.717

Mantovani, 2004, The chemokine system in diverse forms of macrophage activation and polarization, Trends Immunol., 25, 677, 10.1016/j.it.2004.09.015

Rajasingh, 2006, IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression, FASEB J., 20, 2112, 10.1096/fj.06-6084fje